JeNaCell, an Evonik company, launched epicite® CALM at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco during March. Establishing a new gold standard of care in medical aesthetics, epicite® CALM provides optimal post-treatment recovery following laser, light, and energy-based treatments, including fractional CO2 lasers and radiofrequency microneedling.
As the world’s first medical-grade dressing made from biosynthetic cellulose, epicite® CALM will be certified under European Medical Device Regulation (MDR) standards. It offers a safe, sterile, and hypoallergenic option that promotes wound healing while improving patient safety and comfort.
“Biosynthetic cellulose is a material showing superb versatility. Drawing on the extensive clinical experience in treating burns and chronic wounds with products from the epicite® family, we are very pleased to offer epicite® CALM to medical professionals in aesthetics to improve patient outcomes,” said Dr. Dana Kralisch, General Manager of JeNaCell. The Evonik company is a specialist in producing medical-grade products for advanced wound care.
A hydro-active wound dressing, epicite® CALM is designed to create a moist wound environment that promotes healing and minimizes downtime following aesthetic treatments that utilize energy-based technologies, such as CO2 lasers and radiofrequency (RF) microneedling. These procedures enhance collagen production and address signs of aging. However, their intensity can create wounds comparable to minor burns. With some technologies penetrating the dermis up to 7mm, practitioners may face liability risks when using non-medical-grade products on compromised skin.
Made in Germany under stringent cleanroom conditions, epicite® calm is a safe and sterile option for treatment-prone skin and surgical wounds. The product is crafted from natural biosynthetic cellulose, ensuring it is non-occlusive, hypoallergenic, and free from fragrances, preservatives, and parabens.
“epicite® CALM will support medical professionals in enhancing their aftercare protocols to meet medical quality standards. We’re looking forward to partnering with distributors in Europe and internationally to help us bring this exceptional product to patients,” said Julia Born, Business Development & Strategic Marketing Manager at Evonik Health Care.
epicite® CALM hydro active wound dressings are available as face and neck masks
epicite® CALM is the latest addition to JeNaCell’s epicite® family of medical products for advanced wound care and builds on the company’s well-known product portfolio for burn treatment as well as treatment of chronic wounds. Founded in 2012 as a spin-off of the Friedrich Schiller University Jena in Germany, JeNaCell launched its first epicite® product in 2017. Evonik acquired JeNaCell in 2021.
Evonik is a global innovation hub for next-generation biomaterials, working with customers to take their ideas from concept to market. The company provides the industry’s most comprehensive portfolio of tailored materials and services for the manufacture of medical devices that open up new possibilities for patient-specific treatment.
